Orchestrating Resilience: How Neuropilin-2 and Macrophages Contribute to Cardiothoracic Disease
Journal of Clinical Medicine · 01.03.2024 · 13 (5) · 1446
DOI: 10.3390/jcm13051446 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 01.03.2024. Verfasst von Rajeev Dhupar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pennsylvania Department of Health, U.S. Department of Defense, American Lung Association/Thoracic Surgery Foundation.
Abstract (Originalsprache)
Immunity has evolved to balance the destructive nature of inflammation with wound healing to overcome trauma, infection, environmental insults, and rogue malignant cells. The inflammatory response is marked by overlapping phases of initiation, resolution, and post-resolution remodeling. However, the disruption of these events can lead to prolonged tissue damage and organ dysfunction, resulting long-term disease states. Macrophages are the archetypic phagocytes present within all tissues and are important contributors to these processes. Pleiotropic and highly plastic in their responses, macrophages support tissue homeostasis, repair, and regeneration, all while balancing immunologic self-tolerance with the clearance of noxious stimuli, pathogens, and malignant threats. Neuropilin-2 (Nrp2), a promiscuous co-receptor for growth factors, semaphorins, and integrins, has increasingly been recognized for its unique role in tissue homeostasis and immune regulation. Notably, recent studies have begun to elucidate the role of Nrp2 in both non-hematopoietic cells and macrophages with cardiothoracic disease. Herein, we describe the unique role of Nrp2 in diseases of the heart and lung, with an emphasis on Nrp2 in macrophages, and explore the potential to target Nrp2 as a therapeutic intervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
- UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15213, USA.
- Surgical and Research Services, VA Pittsburgh Healthcare System, Pittsburgh, PA 15240, USA.
- Division of Hematology/Oncology, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
- Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA.
- aTyr Pharma, San Diego, CA 92121, USA.
ORCID-Profile: Rajeev Dhupar, Andrea Cubitt, Adam C Soloff
Förderung
- Pennsylvania Department of Health
- U.S. Department of Defense
- American Lung Association/Thoracic Surgery Foundation
- Department of Veteran’s Affairs Career Development Award
- University of Pittsburgh’s Dean Faculty Advancement Award
- Department of Cardiothoracic Surgery
Zitieren
APA
Dhupar, R., Powers, A. A., Eisenberg, S. H., Gemmill, R. M., Bardawil, C. E., Udoh, H. M., Cubitt, A., Nangle, L. A., & Soloff, A. C. (2024). Orchestrating Resilience: How Neuropilin-2 and Macrophages Contribute to Cardiothoracic Disease. Journal of Clinical Medicine, 13(5), 1446. https://doi.org/10.3390/jcm13051446
Vancouver
Dhupar R, Powers AA, Eisenberg SH, Gemmill RM, Bardawil CE, Udoh HM, et al. Orchestrating Resilience: How Neuropilin-2 and Macrophages Contribute to Cardiothoracic Disease. Journal of Clinical Medicine. 2024;13(5):1446. doi:10.3390/jcm13051446
BibTeX
@article{Dhupar2024,
author = {Dhupar, Rajeev and Powers, Amy A and Eisenberg, Seth H and Gemmill, Robert M and Bardawil, Charles E and Udoh, Hannah M and Cubitt, Andrea and Nangle, Leslie A and Soloff, Adam C},
title = {Orchestrating Resilience: How Neuropilin-2 and Macrophages Contribute to Cardiothoracic Disease},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {5},
pages = {1446},
doi = {10.3390/jcm13051446}
}
EUVIMED